Miriam Lichtner

Pubblicazioni

Titolo Pubblicato in Anno
A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice. Evidence of a relevant risk of death and evolution from silent to chronic infection JOURNAL OF VIRAL HEPATITIS 2019
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2019
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? BMC PUBLIC HEALTH 2019
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition JOURNAL OF NEUROCHEMISTRY 2018
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus BIOMED RESEARCH INTERNATIONAL 2018
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 2018
Persistent high plasma levels of sCD163 and sCD14 in adult patients with measles virus infection PLOS ONE 2018
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs) CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 2018
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals. An observational cohort study BMC MEDICINE 2018
Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: A case report MEDICINE 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison HIV MEDICINE 2018
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy BMC PUBLIC HEALTH 2018
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets VIRUSES 2018
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study BMC INFECTIOUS DISEASES 2018
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters IMMUNOBIOLOGY 2018
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy SCIENTIFIC REPORTS 2018
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? JOURNAL OF HEPATOLOGY 2018
Soluble CD163 in CMV-Infected and CMV-Uninfected subjects on virologically suppressive antiretroviral therapy in the ICONA Cohort JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2017
Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: A case report BMC RESEARCH NOTES 2017
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies LIVER INTERNATIONAL 2017

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma